Choueiri, T. K., Xie, W., D’Amico, A. V., Ross, R. W., Hu, J. C., Pomerantz, M., . . . Oh, W. K. (2009). Time to PSA nadir independently predicts overall survival in metastatic hormone sensitive prostate cancer patients treated with androgen deprivation therapy.
シカゴスタイル引用形Choueiri, Toni K., et al. Time to PSA Nadir Independently Predicts Overall Survival in Metastatic Hormone Sensitive Prostate Cancer Patients Treated With Androgen Deprivation Therapy. 2009.
MLA引用形式Choueiri, Toni K., et al. Time to PSA Nadir Independently Predicts Overall Survival in Metastatic Hormone Sensitive Prostate Cancer Patients Treated With Androgen Deprivation Therapy. 2009.
警告: この引用は必ずしも正確ではありません.